 |
New Mountain Capital has spun off Swoop, provider of precision AI-driven healthcare omnichannel solutions, from Real Chemistry.
Swoop operated as a unit of Real Chemistry, which ranks as O’Dwyer’s top ranked healthcare shop, for the past four years.
Its offerings help drug and life sciences brands find, target and engage with their patient and provider audiences.
Ron Elwell, founder/CEO of Swoop, sees the spin-off as a way to execute on an even more expansive shared vision for the business.
He said Swoop will hyper-focus on driving privacy-safe innovation and guide clients as they reimagine how to engage with stakeholders in a data-driven, personalized and digital manner.
Real Chemistry and Swoop will maintain a preferred partnership arrangement.
Swoop has also partnered with Ogilvy Health, Saatchi & Saatchi, FCBHealth, Klick Health, Digital, Evoke, Wunderman Thompson and McCann Health.
H/Advisors Abernathy’s Dana Gorman represents New Mountain Capital, the New York investment firm.
Havas owns H/Advisors.
WPP CEO Cindy Rose unveiled “Elevate 28,” a strategic plan to simplify the troubled company, which reported a 5.4 percent drop in 2025 revenues to $13.6B.
Omnicom CEO John Wren reported a Q4 $977.2M operating loss, largely due to the $1.1B in severance and repositioning expenses connected to the $13B Interpublic takeover that closed on Nov. 26.
Publicis Groupe reports an 8.8 percent rise in 2025 net revenues to $16.4B with
Public Policy Holding Company today priced its initial public offering at $12.25 per share. The sale of 4,150,000 shares raised $50.8M in gross proceeds.
Public Policy Holding Company reports that 4Q '25 revenues surged 27.8 percent to $49.9M. Organic growth rose 5.4 percent.
